Normalized significant family changes in abundance. by Karley K. Mahalak (3212670)

“…<p>A) <i>Erysipelotrichaceae</i> significantly increased with CCE treatment; B) <i>Bacteroidales_unclassified</i> significantly decreased with CCE treatment; C) <i>Desulfovibrionaceae</i> significantly decreased with CCE treatment; D) <i>Rikenellaceae</i> significantly decreased with CCE treatment; E) <i>Coriobacteriaceae</i> significantly decreased with CCE treatment; F) <i>Erysipelotrichaceae</i> significantly increased with TRE treatment.…”

Supplementary Material for: Decreased Quality of Life in patients who desire Body Contouring Surgery after Bariatric Metabolic Surgery: A multicenter longitudinal analysis by Dijkhorst P.J. (20584910)

Results of longitudinal analysis of mental health in HCWs. by A. H. Ayesha Lavell (16734002)

Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma... by figshare admin karger (2628495)

“…Conclusion: In a propensity-score matched analysis of a large national database, individuals with cirrhosis and allopurinol use had significantly lower risk of hepatic decompensation and overall mortality. …”

Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”

Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls by Wen Wang (6570)

“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”

Funnel plots of studies included in the meta-analysis assessing by Solima Sabeel (9545738)

Subjects:

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

Subjects:

Meta-analysis showing the overall effect of different statin types versus placebo for by Solima Sabeel (9545738)

Subjects:

Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for by Solima Sabeel (9545738)

Subjects:

Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

Subjects:

Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Subjects:

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Analysis of randomized controlled trials stratified based on treatment duration. by Solima Sabeel (9545738)

Subjects:

PRISMA flow diagram of the systematic literature search process. by Solima Sabeel (9545738)

Subjects:

Excluded skewed studies. by Solima Sabeel (9545738)

Subjects:

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Summary of non-randomized studies. by Solima Sabeel (9545738)

Subjects: